Estrogen Receptor Antagonist [EPC]

Estrogen Receptor Antagonist [EPC] was reported 40549 times

Drugs of the Estrogen Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PIK3CA-ACTIVATED MUTATION 167 0.5030
1 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 133 0.4006
2 CARBOHYDRATE ANTIGEN 27.29 INCREASED 53 0.3533
3 CARBOHYDRATE ANTIGEN 15-3 INCREASED 264 0.3469
4 ELLIPTOCYTOSIS 26 0.2889
5 INFUSION SITE COLDNESS 24 0.2400
6 PSEUDOCIRRHOSIS 79 0.2380
7 TUMOUR MARKER ABNORMAL 64 0.1934
8 TUMOUR MARKER INCREASED 900 0.1874
9 METASTASES TO THORAX 47 0.1858
10 METASTASES TO EYE 39 0.1781
11 PLEURAL NEOPLASM 29 0.1758
12 METASTASES TO SPINAL CORD 34 0.1753
13 METASTASES TO PLEURA 173 0.1649
14 BREAST CANCER METASTATIC 1706 0.1587
15 METASTASES TO SKIN 163 0.1578
16 TUMOUR MARKER DECREASED 28 0.1564
17 METASTASES TO BONE 2233 0.1359
18 METASTASES TO CHEST WALL 46 0.1326
19 METASTASES TO BREAST 43 0.1295
20 GAMMA-GLUTAMYLTRANSFERASE DECREASED 24 0.1250
21 NAIL BED INFLAMMATION 39 0.1223
22 ADNEXA UTERI MASS 35 0.1211
23 MUSCULOSKELETAL TOXICITY 22 0.1183
24 METASTASES TO LIVER 1834 0.1042
25 CHEST WALL MASS 27 0.1038
26 METASTASES TO PELVIS 64 0.1013
27 HORMONE RECEPTOR POSITIVE BREAST CANCER 27 0.0993
28 BREAST CANCER RECURRENT 313 0.0990
29 METASTASES TO SPINE 330 0.0981
30 METASTASES TO THE MEDIASTINUM 40 0.0971
31 INTESTINAL METASTASIS 35 0.0964
32 SCAN ABNORMAL 35 0.0949
33 METASTASES TO OVARY 29 0.0909
34 OESTRADIOL INCREASED 25 0.0831
35 BONE MARROW INFILTRATION 32 0.0827
36 INVASIVE LOBULAR BREAST CARCINOMA 42 0.0819
37 POSITRON EMISSION TOMOGRAM ABNORMAL 57 0.0815
38 NASAL MUCOSAL DISORDER 47 0.0806
39 METASTASES TO NECK 22 0.0789
40 BONE LESION 271 0.0751
41 CARCINOEMBRYONIC ANTIGEN INCREASED 141 0.0727
42 INVASIVE BREAST CARCINOMA 30 0.0726
43 METASTASES TO BONE MARROW 36 0.0720
44 METASTASES TO LYMPH NODES 472 0.0699
45 METASTASES TO LUNG 805 0.0696
46 NEOPLASM PROGRESSION 2208 0.0634
47 BONE CANCER METASTATIC 33 0.0624
48 METASTASES TO STOMACH 24 0.0612
49 BLOOD ALBUMIN ABNORMAL 31 0.0595
50 METASTASES TO PERITONEUM 148 0.0585
51 OSTEOSCLEROSIS 92 0.0584
52 ANISOCYTOSIS 38 0.0578
53 OSTEOLYSIS 113 0.0552
54 HYPERMETABOLISM 29 0.0547
55 METASTASIS 375 0.0525
56 MALIGNANT PLEURAL EFFUSION 88 0.0521
57 PRIMARY SEQUESTRUM 47 0.0519
58 MENINGOENCEPHALITIS HERPETIC 23 0.0513
59 PLEURAL THICKENING 34 0.0497
60 STREPTOCOCCAL SEPSIS 58 0.0489
61 INVASIVE DUCTAL BREAST CARCINOMA 131 0.0481
62 METASTASES TO ADRENALS 41 0.0444
63 HEPATIC LESION 192 0.0444
64 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 55 0.0441
65 MALIGNANT NEOPLASM PROGRESSION 4502 0.0439
66 CANCER PAIN 112 0.0438
67 DECREASED IMMUNE RESPONSIVENESS 426 0.0434
68 MEAN CELL HAEMOGLOBIN INCREASED 71 0.0428
69 VERTEBRAL FORAMINAL STENOSIS 35 0.0425
70 PLEURAL DISORDER 26 0.0414
71 HILAR LYMPHADENOPATHY 36 0.0409
72 BLOOD BILIRUBIN ABNORMAL 51 0.0398
73 ABDOMINAL LYMPHADENOPATHY 33 0.0380
74 LYMPHANGIOSIS CARCINOMATOSA 39 0.0374
75 MALIGNANT ASCITES 28 0.0365
76 INTERVERTEBRAL DISC SPACE NARROWING 27 0.0335
77 EXCESSIVE GRANULATION TISSUE 27 0.0335
78 LYMPHADENOPATHY MEDIASTINAL 64 0.0334
79 BASOPHIL COUNT INCREASED 25 0.0330
80 MEAN CELL VOLUME INCREASED 84 0.0327
81 METASTASES TO CENTRAL NERVOUS SYSTEM 406 0.0314
82 FOREIGN BODY IN THROAT 97 0.0308
83 PLEURAL FIBROSIS 31 0.0304
84 PSEUDOMONAL SEPSIS 53 0.0302
85 EXPOSED BONE IN JAW 65 0.0300
86 BONE NEOPLASM 32 0.0297
87 POST-TRAUMATIC NECK SYNDROME 24 0.0297
88 OSTEONECROSIS OF JAW 700 0.0283
89 HEPATIC MASS 54 0.0280
90 BLOOD ALKALINE PHOSPHATASE ABNORMAL 25 0.0278
91 LYMPHOEDEMA 189 0.0273
92 SECOND PRIMARY MALIGNANCY 221 0.0265
93 INJECTION SITE NECROSIS 54 0.0265
94 DILATED CARDIOMYOPATHY 26 0.0257
95 BLOOD CALCIUM ABNORMAL 42 0.0252
96 GENE MUTATION 50 0.0252
97 METASTASES TO MENINGES 57 0.0250
98 MACROCYTOSIS 29 0.0250
99 MONOCYTE COUNT DECREASED 30 0.0246
100 OVARIAN DISORDER 23 0.0245
101 TUMOUR PAIN 32 0.0243
102 FRACTURED SACRUM 30 0.0241
103 NEUTROPHIL COUNT ABNORMAL 67 0.0237
104 ACQUIRED GENE MUTATION 31 0.0236
105 RED CELL DISTRIBUTION WIDTH INCREASED 97 0.0233
106 BLOOD CREATININE ABNORMAL 80 0.0231
107 HEPATIC CYST 78 0.0229
108 PATHOLOGICAL FRACTURE 115 0.0226
109 BILE DUCT STENOSIS 27 0.0225
110 VASCULAR CALCIFICATION 23 0.0216
111 WHITE BLOOD CELL COUNT DECREASED 2299 0.0212
112 NEOPLASM RECURRENCE 71 0.0209
113 NEUTROPHIL COUNT DECREASED 851 0.0209
114 ALANINE AMINOTRANSFERASE ABNORMAL 44 0.0208
115 BODY MASS INDEX INCREASED 28 0.0207
116 BONE CANCER 89 0.0204
117 METASTATIC NEOPLASM 88 0.0204
118 ABSCESS JAW 21 0.0202
119 HYPERGLYCAEMIA 734 0.0201
120 RED BLOOD CELL COUNT DECREASED 570 0.0199
121 ASPARTATE AMINOTRANSFERASE ABNORMAL 30 0.0197
122 VULVOVAGINAL DRYNESS 62 0.0192
123 WHITE BLOOD CELL COUNT ABNORMAL 120 0.0188
124 NEUTROPENIA 2553 0.0188
125 SKIN TOXICITY 106 0.0187
126 SUPERINFECTION 27 0.0180
127 AORTIC ARTERIOSCLEROSIS 46 0.0179
128 FULL BLOOD COUNT ABNORMAL 189 0.0179
129 PERIODONTAL DISEASE 25 0.0178
130 DISEASE PROGRESSION 2109 0.0178
131 FULL BLOOD COUNT DECREASED 357 0.0177
132 BREAST CANCER STAGE IV 50 0.0176
133 DISCOURAGEMENT 41 0.0175
134 RED BLOOD CELL COUNT ABNORMAL 25 0.0170
135 ONYCHOCLASIS 117 0.0170
136 MEAN CELL HAEMOGLOBIN DECREASED 31 0.0169
137 BLOOD CREATININE DECREASED 53 0.0169
138 PERIODONTITIS 36 0.0166
139 HEPATIC NEOPLASM 54 0.0165
140 ADENOCARCINOMA 37 0.0165
141 MUCOSAL DRYNESS 33 0.0164
142 PORTAL HYPERTENSION 50 0.0162
143 WHITE BLOOD CELL DISORDER 43 0.0161
144 PULMONARY MASS 237 0.0159
145 SPINAL PAIN 185 0.0158
146 VOCAL CORD PARALYSIS 28 0.0156
147 RADICULOPATHY 41 0.0155
148 INFUSION SITE INDURATION 23 0.0155
149 ASCITES 453 0.0154
150 POLYNEUROPATHY 179 0.0149
151 LEUKOPENIA 745 0.0149
152 PARONYCHIA 65 0.0148
153 BONE PAIN 858 0.0146
154 BONE DISORDER 262 0.0144
155 MUSCULOSKELETAL CHEST PAIN 222 0.0143
156 NAIL DISORDER 124 0.0142
157 PRODUCT SIZE ISSUE 75 0.0139
158 HAEMATOTOXICITY 132 0.0139
159 SPONDYLOLISTHESIS 24 0.0138
160 BREAST DISORDER 28 0.0137
161 VITILIGO 32 0.0136
162 PLEURAL EFFUSION 816 0.0134
163 RECURRENT CANCER 54 0.0132
164 URINE ODOUR ABNORMAL 77 0.0131
165 HAEMOGLOBIN ABNORMAL 84 0.0130
166 LOOSE TOOTH 42 0.0130
167 BREAST MASS 87 0.0129
168 BONE MARROW DISORDER 39 0.0129
169 PROTEIN TOTAL INCREASED 34 0.0128
170 NEOPLASM 146 0.0127
171 JAW DISORDER 69 0.0126
172 KYPHOSIS 22 0.0124
173 CONCOMITANT DISEASE AGGRAVATED 75 0.0121
174 SPINAL CORD COMPRESSION 47 0.0121
175 VARICOSE VEIN 62 0.0120
176 VASCULAR DEVICE INFECTION 54 0.0119
177 OSTEITIS 30 0.0119
178 VEIN DISORDER 58 0.0116
179 GINGIVAL SWELLING 51 0.0115
180 BREAST SWELLING 31 0.0115
181 GINGIVITIS 62 0.0115
182 MUCOSAL INFLAMMATION 300 0.0114
183 PORTAL VEIN THROMBOSIS 37 0.0114
184 ERYTHEMA MULTIFORME 105 0.0112
185 HAEMANGIOMA 26 0.0112
186 BLOOD COUNT ABNORMAL 170 0.0112
187 STOMATITIS 677 0.0112
188 JAW FRACTURE 24 0.0111
189 MYELOSUPPRESSION 396 0.0110
190 ORAL PAIN 246 0.0110
191 BREAST PAIN 117 0.0110
192 HYDRONEPHROSIS 82 0.0109
193 PLATELET COUNT ABNORMAL 66 0.0109
194 SPINAL OSTEOARTHRITIS 95 0.0108
195 ERYSIPELAS 54 0.0107
196 APHTHOUS ULCER 83 0.0107
197 HOSPICE CARE 104 0.0105
198 BREAST CANCER 965 0.0103
199 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 241 0.0103
200 VASODILATATION 26 0.0103
201 CACHEXIA 53 0.0103
202 CARBOHYDRATE ANTIGEN 125 INCREASED 35 0.0103
203 GINGIVAL PAIN 81 0.0102
204 LYMPHADENITIS 24 0.0099
205 HAEMATOCRIT DECREASED 195 0.0098
206 LYMPHADENOPATHY 348 0.0098
207 PNEUMONITIS 267 0.0098
208 HOT FLUSH 732 0.0097
209 PERIARTHRITIS 22 0.0097
210 DIVERTICULUM INTESTINAL 42 0.0096
211 GASTROINTESTINAL TOXICITY 46 0.0096
212 HEPATOTOXICITY 211 0.0095
213 PIGMENTATION DISORDER 58 0.0094
214 BODY HEIGHT DECREASED 100 0.0093
215 ATELECTASIS 90 0.0093
216 BONE MARROW FAILURE 187 0.0092
217 TOOTHACHE 166 0.0092
218 HEPATOMEGALY 90 0.0091
219 ORAL DISORDER 67 0.0091
220 HEPATIC PAIN 39 0.0091
221 HYPERTRANSAMINASAEMIA 63 0.0090
222 HEPATIC FAILURE 271 0.0090
223 TASTE DISORDER 182 0.0090
224 NASAL DRYNESS 56 0.0089
225 PURULENT DISCHARGE 38 0.0089
226 NECK MASS 25 0.0088
227 MASTICATION DISORDER 27 0.0088
228 OESOPHAGEAL STENOSIS 25 0.0088
229 PROTEIN TOTAL DECREASED 33 0.0088
230 BLOOD TEST ABNORMAL 123 0.0087
231 DIASTOLIC DYSFUNCTION 27 0.0087
232 LUNG OPACITY 23 0.0087
233 PLATELET DISORDER 22 0.0087
234 SKIN MASS 58 0.0087
235 LIVER FUNCTION TEST INCREASED 186 0.0087
236 CYTOPENIA 106 0.0086
237 OSTEOMYELITIS 155 0.0086
238 GOITRE 35 0.0085
239 MONOCYTE COUNT INCREASED 31 0.0085
240 DENTAL CARIES 94 0.0085
241 PAIN IN JAW 240 0.0085
242 PLATELET COUNT DECREASED 897 0.0084
243 GLOMERULAR FILTRATION RATE DECREASED 103 0.0084
244 TRANSAMINASES INCREASED 185 0.0083
245 PAROSMIA 62 0.0082
246 BLOOD ALKALINE PHOSPHATASE INCREASED 204 0.0082
247 ORAL INFECTION 32 0.0082
248 FEEDING DISORDER 166 0.0082
249 CEREBRAL THROMBOSIS 23 0.0081
250 THORACIC VERTEBRAL FRACTURE 24 0.0081
251 SCIATICA 128 0.0080
252 OVARIAN CANCER 74 0.0080
253 PRODUCT USE COMPLAINT 126 0.0080
254 DECREASED APPETITE 1855 0.0080
255 THYROID NEOPLASM 22 0.0080
256 MOUTH SWELLING 46 0.0080
257 TRICUSPID VALVE INCOMPETENCE 63 0.0079
258 HAEMOGLOBIN DECREASED 813 0.0079
259 GRANULOCYTOPENIA 45 0.0079
260 EATING DISORDER 168 0.0079
261 ODYNOPHAGIA 47 0.0079
262 HEPATIC ENZYME ABNORMAL 39 0.0078
263 GINGIVAL DISORDER 30 0.0078
264 OESOPHAGITIS 85 0.0078
265 THROMBOCYTOPENIA 867 0.0077
266 NODULE 101 0.0077
267 BLOOD CALCIUM DECREASED 87 0.0077
268 ALOPECIA 1503 0.0076
269 BLOOD CALCIUM INCREASED 67 0.0076
270 CLAVICLE FRACTURE 29 0.0076
271 RENAL CYST 60 0.0075
272 TOOTH EXTRACTION 94 0.0075
273 PULMONARY PAIN 22 0.0075
274 EJECTION FRACTION DECREASED 117 0.0075
275 GAMMA-GLUTAMYLTRANSFERASE INCREASED 165 0.0074
276 ACUTE LYMPHOCYTIC LEUKAEMIA 21 0.0074
277 THROMBOPHLEBITIS 26 0.0074
278 FACET JOINT SYNDROME 24 0.0074
279 BRAIN OEDEMA 93 0.0074
280 TOOTH FRACTURE 81 0.0073
281 GLOSSITIS 26 0.0073
282 ASPARTATE AMINOTRANSFERASE INCREASED 389 0.0073
283 PRODUCT DOSE OMISSION IN ERROR 206 0.0073
284 MASS 101 0.0072
285 BLOOD BILIRUBIN INCREASED 195 0.0072
286 NEUROPATHY PERIPHERAL 686 0.0072
287 RHINITIS ALLERGIC 32 0.0072
288 ANAEMIA 1370 0.0072
289 RECTAL CANCER 22 0.0072
290 LUNG INFILTRATION 63 0.0071
291 THERAPY PARTIAL RESPONDER 111 0.0071
292 SCOLIOSIS 44 0.0071
293 COMPRESSION FRACTURE 38 0.0071
294 APPETITE DISORDER 47 0.0071
295 HEPATIC STEATOSIS 132 0.0071
296 SPINAL COMPRESSION FRACTURE 58 0.0070
297 INFUSION SITE HAEMORRHAGE 23 0.0070
298 DYSPNOEA EXERTIONAL 260 0.0069
299 FATIGUE 5334 0.0068
300 HYPERCALCAEMIA 84 0.0068
301 LYMPHOCYTE COUNT INCREASED 22 0.0067
302 SYNOVIAL CYST 31 0.0067
303 TOOTH ABSCESS 68 0.0067
304 LABORATORY TEST ABNORMAL 197 0.0067
305 HAIR GROWTH ABNORMAL 46 0.0066
306 IMMUNODEFICIENCY 99 0.0066
307 DECREASED INTEREST 39 0.0066
308 SKIN ATROPHY 38 0.0066
309 OSTEONECROSIS 216 0.0066
310 SPINAL COLUMN STENOSIS 31 0.0066
311 TONGUE ULCERATION 22 0.0065
312 FLANK PAIN 61 0.0065
313 INTERSTITIAL LUNG DISEASE 315 0.0065
314 PHLEBITIS 33 0.0064
315 OROPHARYNGEAL DISCOMFORT 58 0.0064
316 CANDIDA INFECTION 108 0.0064
317 BLOOD CREATININE INCREASED 417 0.0064
318 GENERAL PHYSICAL HEALTH DETERIORATION 737 0.0064
319 TRIGGER FINGER 26 0.0064
320 LACRIMATION INCREASED 192 0.0063
321 HIATUS HERNIA 82 0.0063
322 OSTEOPENIA 96 0.0063
323 RHINITIS 51 0.0063
324 FOOD INTOLERANCE 23 0.0063
325 INTERVERTEBRAL DISC DEGENERATION 58 0.0063
326 THYROID MASS 24 0.0062
327 MADAROSIS 72 0.0062
328 ONYCHOMADESIS 26 0.0062
329 YELLOW SKIN 29 0.0062
330 LIVER DISORDER 274 0.0062
331 HORMONE LEVEL ABNORMAL 30 0.0061
332 HYPERPYREXIA 26 0.0061
333 GASTRITIS 161 0.0061
334 CONSTIPATION 1334 0.0061
335 TOOTH DISORDER 136 0.0061
336 NAIL DISCOLOURATION 24 0.0061
337 SKIN ODOUR ABNORMAL 24 0.0061
338 HEPATIC CIRRHOSIS 114 0.0061
339 FEMORAL NECK FRACTURE 31 0.0060
340 SPINAL DISORDER 57 0.0060
341 IMMUNOSUPPRESSION 53 0.0060
342 MITRAL VALVE INCOMPETENCE 67 0.0059
343 HYPOALBUMINAEMIA 46 0.0059
344 DYSPEPSIA 582 0.0059
345 BLOOD URIC ACID INCREASED 34 0.0059
346 CARDIOMEGALY 72 0.0058
347 JAUNDICE 156 0.0058
348 FEELING COLD 161 0.0058
349 IRON DEFICIENCY 26 0.0058
350 OVERWEIGHT 31 0.0058
351 NAUSEA 4565 0.0058
352 OCULAR ICTERUS 25 0.0058
353 DRUG INTOLERANCE 557 0.0058
354 ALANINE AMINOTRANSFERASE INCREASED 354 0.0058
355 RIB FRACTURE 117 0.0057
356 BUNDLE BRANCH BLOCK LEFT 24 0.0057
357 LYMPHOCYTE COUNT DECREASED 99 0.0056
358 ARTERIOSCLEROSIS CORONARY ARTERY 37 0.0056
359 OESOPHAGEAL PAIN 22 0.0056
360 TOOTH INFECTION 73 0.0055
361 SKIN FISSURES 107 0.0055
362 TRIGEMINAL NEURALGIA 22 0.0055
363 ASTHENIA 2056 0.0055
364 MUSCULOSKELETAL DISCOMFORT 94 0.0055
365 IMPAIRED HEALING 179 0.0054
366 VITAMIN D DEFICIENCY 53 0.0054
367 BACK PAIN 1260 0.0054
368 MOUTH ULCERATION 114 0.0054
369 VITAMIN D DECREASED 46 0.0054
370 PULMONARY TOXICITY 38 0.0054
371 PERFORMANCE STATUS DECREASED 25 0.0054
372 GROIN PAIN 47 0.0053
373 HEPATIC FUNCTION ABNORMAL 199 0.0053
374 STRESS CARDIOMYOPATHY 31 0.0053
375 PERIPHERAL SENSORY NEUROPATHY 31 0.0053
376 MUSCULOSKELETAL PAIN 277 0.0053
377 PANCYTOPENIA 294 0.0053
378 EXOSTOSIS 48 0.0053
379 ELECTROCARDIOGRAM QT PROLONGED 189 0.0052
380 CEREBRAL ISCHAEMIA 27 0.0052
381 HAEMORRHOIDS 102 0.0052
382 AGEUSIA 130 0.0052
383 NECROSIS 29 0.0052
384 TENDERNESS 54 0.0052
385 INTERVERTEBRAL DISC DISORDER 22 0.0051
386 DRUG RESISTANCE 131 0.0051
387 HAIR TEXTURE ABNORMAL 68 0.0051
388 JOINT EFFUSION 35 0.0051
389 CARDIOTOXICITY 45 0.0050
390 BLOOD ALBUMIN DECREASED 40 0.0050
391 HYPERLIPIDAEMIA 60 0.0050
392 DIARRHOEA 3231 0.0050
393 NEUTROPHIL COUNT INCREASED 51 0.0050
394 PHYSICAL DISABILITY 22 0.0050
395 EMBOLISM 41 0.0049
396 BLOOD LACTATE DEHYDROGENASE INCREASED 78 0.0049
397 INCONTINENCE 52 0.0049
398 PRODUCT SUPPLY ISSUE 35 0.0049
399 SKIN LESION 134 0.0049
400 BLOOD MAGNESIUM DECREASED 42 0.0049
401 VOMITING 2288 0.0049
402 PERICARDIAL EFFUSION 112 0.0048
403 PULMONARY OEDEMA 214 0.0048
404 BLOOD UREA INCREASED 80 0.0048
405 PELVIC FRACTURE 37 0.0047
406 ILLNESS 489 0.0047
407 FAECALOMA 26 0.0047
408 BLOOD CHOLESTEROL INCREASED 220 0.0047
409 FEELING OF DESPAIR 22 0.0047
410 ENDOCARDITIS 24 0.0047
411 PLATELET COUNT INCREASED 61 0.0047
412 EPISTAXIS 349 0.0047
413 RETCHING 98 0.0046
414 SENSORY LOSS 37 0.0046
415 COUGH 1286 0.0046
416 CENTRAL NERVOUS SYSTEM LESION 63 0.0046
417 NEURALGIA 111 0.0046
418 LIMB DISCOMFORT 141 0.0046
419 FAECES SOFT 33 0.0045
420 ABDOMINAL DISCOMFORT 758 0.0045
421 LIP DRY 41 0.0045
422 NERVE INJURY 50 0.0045
423 BLOOD GLUCOSE ABNORMAL 83 0.0045
424 HYPOCALCAEMIA 85 0.0045
425 LIVER INJURY 110 0.0045
426 FOOD POISONING 24 0.0045
427 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
428 DEHYDRATION 597 0.0045
429 SENSITIVE SKIN 33 0.0045
430 GINGIVAL BLEEDING 61 0.0045
431 GASTROOESOPHAGEAL REFLUX DISEASE 357 0.0044
432 MUSCLE ATROPHY 56 0.0044
433 DECUBITUS ULCER 36 0.0044
434 SKIN DISORDER 147 0.0044
435 HYPERTENSIVE CRISIS 49 0.0044
436 DIABETIC KETOACIDOSIS 105 0.0044
437 WOUND 122 0.0044
438 CHOKING 85 0.0044
439 BRAIN NEOPLASM 40 0.0043
440 WEIGHT DECREASED 1205 0.0043
441 METABOLIC DISORDER 25 0.0043
442 SENSORY DISTURBANCE 69 0.0043
443 MOVEMENT DISORDER 138 0.0043
444 ARTHRALGIA 1781 0.0043
445 FRACTURE 81 0.0043
446 ECCHYMOSIS 29 0.0042
447 DYSPHAGIA 401 0.0042
448 HEPATITIS 108 0.0042
449 C-REACTIVE PROTEIN INCREASED 153 0.0042
450 MALNUTRITION 47 0.0042
451 ENTEROCOLITIS 24 0.0042
452 BRONCHIECTASIS 28 0.0042
453 TONGUE DISORDER 30 0.0041
454 ARTERIOSCLEROSIS 39 0.0041
455 BLOOD SODIUM DECREASED 78 0.0041
456 RETINAL DETACHMENT 38 0.0041
457 DRY THROAT 42 0.0041
458 GENERAL PHYSICAL CONDITION ABNORMAL 28 0.0041
459 PULMONARY EMBOLISM 392 0.0041
460 BLOOD POTASSIUM DECREASED 124 0.0041
461 CYSTITIS 131 0.0041
462 FISTULA 46 0.0041
463 DRY SKIN 545 0.0041
464 BLOOD POTASSIUM INCREASED 66 0.0041
465 MUSCLE STRAIN 35 0.0040
466 PULMONARY THROMBOSIS 44 0.0040
467 FACIAL PAIN 36 0.0040
468 INTERVERTEBRAL DISC PROTRUSION 88 0.0040
469 DYSGEUSIA 299 0.0040
470 HEPATIC ENZYME INCREASED 274 0.0040
471 HYPOKALAEMIA 185 0.0040
472 HAIR DISORDER 33 0.0040
473 CELLULITIS 200 0.0040
474 DERMATITIS 83 0.0040
475 EAR PAIN 77 0.0040
476 LUNG DISORDER 194 0.0040
477 ORAL DISCOMFORT 55 0.0040
478 GAIT INABILITY 132 0.0039
479 DIVERTICULUM 28 0.0039
480 HAEMATOMA 102 0.0039
481 HYPERCHOLESTEROLAEMIA 38 0.0039
482 GASTROINTESTINAL PAIN 43 0.0039
483 POLYURIA 32 0.0039
484 RENAL IMPAIRMENT 327 0.0039
485 DISCOMFORT 237 0.0039
486 DRY MOUTH 314 0.0039
487 IMMUNE SYSTEM DISORDER 51 0.0039
488 POOR VENOUS ACCESS 40 0.0039
489 BODY TEMPERATURE DECREASED 38 0.0039
490 SCAR 66 0.0039
491 DEPRESSED MOOD 203 0.0038
492 DEATH 3297 0.0038
493 DERMATITIS ALLERGIC 48 0.0038
494 PHARYNGITIS 47 0.0038
495 INJECTION SITE MASS 140 0.0038
496 CORONAVIRUS INFECTION 25 0.0038
497 PAIN IN EXTREMITY 1113 0.0038
498 OSTEOPOROSIS 155 0.0038
499 UPPER-AIRWAY COUGH SYNDROME 31 0.0038
500 DYSPHONIA 220 0.0038
501 MYALGIA 639 0.0038
502 OSTEOARTHRITIS 159 0.0037
503 PELVIC PAIN 68 0.0037
504 BRAIN FOG 58 0.0037
505 THIRST 66 0.0037
506 UTERINE LEIOMYOMA 27 0.0037
507 PYELONEPHRITIS 32 0.0037
508 RENAL PAIN 39 0.0037
509 SKELETAL INJURY 38 0.0037
510 HEAD DISCOMFORT 65 0.0037
511 URINARY TRACT INFECTION 625 0.0037
512 BOWEL MOVEMENT IRREGULARITY 28 0.0037
513 HYPOAESTHESIA ORAL 55 0.0036
514 HEPATIC ENCEPHALOPATHY 34 0.0036
515 INJECTION SITE NODULE 40 0.0036
516 INFLAMMATION 187 0.0036
517 BLOOD DISORDER 29 0.0036
518 DIABETES MELLITUS 275 0.0036
519 NEOPLASM MALIGNANT 240 0.0036
520 PNEUMOTHORAX 57 0.0036
521 ULCER 57 0.0036
522 APHONIA 50 0.0036
523 LIVER FUNCTION TEST ABNORMAL 104 0.0036
524 HYPERBILIRUBINAEMIA 37 0.0036
525 PRODUCTIVE COUGH 170 0.0036
526 SPINAL FRACTURE 71 0.0035
527 BLOOD PRESSURE DIASTOLIC DECREASED 26 0.0035
528 ABDOMINAL PAIN UPPER 724 0.0035
529 SCRATCH 37 0.0035
530 BRONCHOSPASM 50 0.0035
531 PAIN 2150 0.0035
532 SMALL INTESTINAL OBSTRUCTION 43 0.0035
533 PERIPHERAL SWELLING 536 0.0035
534 SKIN REACTION 49 0.0035
535 SLEEP DISORDER 244 0.0035
536 OROPHARYNGEAL PAIN 320 0.0035
537 DYSURIA 127 0.0034
538 ELECTROLYTE IMBALANCE 40 0.0034
539 DECREASED ACTIVITY 37 0.0034
540 OEDEMA PERIPHERAL 418 0.0034
541 GAIT DISTURBANCE 656 0.0034
542 ABNORMAL FAECES 28 0.0034
543 THROAT IRRITATION 153 0.0034
544 CHILLS 397 0.0034
545 ILEUS 42 0.0034
546 BLOOD THYROID STIMULATING HORMONE INCREASED 31 0.0034
547 ACUTE HEPATIC FAILURE 46 0.0034
548 DRY EYE 168 0.0034
549 PYREXIA 1162 0.0034
550 PETECHIAE 35 0.0034
551 CONJUNCTIVITIS 62 0.0033
552 PULMONARY CONGESTION 44 0.0033
553 MUSCLE DISORDER 27 0.0033
554 ABDOMINAL DISTENSION 348 0.0033
555 INJECTION SITE DISCOMFORT 35 0.0033
556 COVID-19 582 0.0033
557 FLATULENCE 187 0.0033
558 HYPOAESTHESIA 493 0.0033
559 FEMUR FRACTURE 102 0.0033
560 CHOLELITHIASIS 108 0.0033
561 SKIN ULCER 85 0.0033
562 DYSSTASIA 96 0.0033
563 BLOOD TRIGLYCERIDES INCREASED 58 0.0033
564 TOOTH LOSS 68 0.0033
565 NASAL DISCOMFORT 26 0.0033
566 JOINT STIFFNESS 86 0.0033
567 CHOLECYSTITIS 39 0.0033
568 BONE LOSS 49 0.0033
569 RASH 1414 0.0032
570 THERMAL BURN 23 0.0032
571 LIGAMENT SPRAIN 32 0.0032
572 SKIN DISCOLOURATION 148 0.0032
573 BLOOD PRESSURE ABNORMAL 64 0.0032
574 MALAISE 1409 0.0032
575 GASTROENTERITIS VIRAL 58 0.0032
576 ASPHYXIA 26 0.0032
577 WHITE BLOOD CELL COUNT INCREASED 122 0.0032
578 NIGHT SWEATS 102 0.0032
579 HYPERAESTHESIA 26 0.0032
580 DYSPNOEA 1784 0.0031
581 BURSITIS 38 0.0031
582 PRODUCT AVAILABILITY ISSUE 71 0.0031
583 NECK PAIN 174 0.0031
584 ANAL INCONTINENCE 28 0.0031
585 BREAST CANCER FEMALE 83 0.0031
586 DEFORMITY 29 0.0031
587 HYPOKINESIA 45 0.0031
588 THROMBOSIS 249 0.0031
589 ABDOMINAL PAIN 719 0.0031
590 INCREASED APPETITE 59 0.0031
591 PNEUMOCYSTIS JIROVECII PNEUMONIA 31 0.0031
592 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0031
593 DRUG-INDUCED LIVER INJURY 96 0.0031
594 HAIR COLOUR CHANGES 38 0.0031
595 BLOOD IRON DECREASED 36 0.0030
596 OEDEMA 164 0.0030
597 LOCALISED INFECTION 73 0.0030
598 HIP FRACTURE 97 0.0030
599 HYPOPHAGIA 77 0.0030
600 ABSCESS 48 0.0030
601 RASH PRURITIC 163 0.0030
602 HYPERSOMNIA 86 0.0030
603 CARDIOMYOPATHY 44 0.0030
604 CHROMATURIA 67 0.0030
605 SECRETION DISCHARGE 37 0.0030
606 ELECTROCARDIOGRAM ABNORMAL 23 0.0029
607 CARPAL TUNNEL SYNDROME 41 0.0029
608 IRON DEFICIENCY ANAEMIA 27 0.0029
609 SUPRAVENTRICULAR TACHYCARDIA 28 0.0029
610 PERIPHERAL COLDNESS 40 0.0029
611 RED BLOOD CELL SEDIMENTATION RATE INCREASED 32 0.0029
612 CONTUSION 278 0.0029
613 ORAL HERPES 56 0.0029
614 ERUCTATION 55 0.0028
615 POLLAKIURIA 118 0.0028
616 LYMPHOPENIA 40 0.0028
617 HEPATIC CYTOLYSIS 36 0.0028
618 UROSEPSIS 26 0.0028
619 GLOSSODYNIA 63 0.0028
620 PRODUCT DISTRIBUTION ISSUE 26 0.0028
621 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48 0.0028
622 EMPHYSEMA 28 0.0028
623 NERVOUSNESS 145 0.0028
624 SKIN EXFOLIATION 234 0.0028
625 THROMBOTIC MICROANGIOPATHY 27 0.0028
626 VAGINAL DISCHARGE 28 0.0028
627 HYPOTHYROIDISM 88 0.0028
628 HEPATOCELLULAR INJURY 39 0.0027
629 ISCHAEMIC STROKE 49 0.0027
630 ASPIRATION 30 0.0027
631 CATARACT 163 0.0027
632 MEMORY IMPAIRMENT 375 0.0027
633 INFECTION 395 0.0027
634 URINARY RETENTION 91 0.0027
635 PARALYSIS 39 0.0027
636 OVARIAN CYST 27 0.0027
637 SWELLING 251 0.0027
638 ARRHYTHMIA 127 0.0027
639 DIZZINESS POSTURAL 26 0.0027
640 BURNING SENSATION 188 0.0027
641 HAEMOLYTIC ANAEMIA 24 0.0027
642 THERAPY CESSATION 137 0.0027
643 TREATMENT FAILURE 221 0.0027
644 SKIN LACERATION 29 0.0027
645 MUSCULAR WEAKNESS 303 0.0027
646 UPPER RESPIRATORY TRACT INFECTION 123 0.0027
647 THYROID DISORDER 41 0.0027
648 CARDIAC MURMUR 23 0.0027
649 POOR QUALITY SLEEP 57 0.0026
650 HYPERTENSION 558 0.0026
651 HEAD INJURY 83 0.0026
652 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
653 MUSCLE SPASMS 478 0.0026
654 BLOOD GLUCOSE INCREASED 487 0.0026
655 MULTIPLE ORGAN DYSFUNCTION SYNDROME 73 0.0026
656 RESTLESSNESS 94 0.0026
657 URINARY INCONTINENCE 76 0.0026
658 COLITIS 97 0.0026
659 NASOPHARYNGITIS 470 0.0025
660 SLUGGISHNESS 26 0.0025
661 DIZZINESS 1265 0.0025
662 INFLUENZA 282 0.0025
663 CHEST PAIN 468 0.0025
664 DIVERTICULITIS 70 0.0025
665 BACTERIAL INFECTION 47 0.0025
666 PARAESTHESIA 396 0.0025
667 PNEUMONIA BACTERIAL 23 0.0025
668 VENTRICULAR EXTRASYSTOLES 26 0.0025
669 LIMB INJURY 68 0.0025
670 PULMONARY FIBROSIS 48 0.0025
671 PARAESTHESIA ORAL 36 0.0025
672 DEEP VEIN THROMBOSIS 162 0.0025
673 NERVE COMPRESSION 23 0.0025
674 DRUG ERUPTION 44 0.0025
675 PRURITUS 947 0.0025
676 MICTURITION URGENCY 28 0.0024
677 HYPOMAGNESAEMIA 34 0.0024
678 VISUAL IMPAIRMENT 302 0.0024
679 CARDIAC FAILURE 195 0.0024
680 FEELING ABNORMAL 582 0.0024
681 RENAL DISORDER 113 0.0024
682 TEMPERATURE INTOLERANCE 25 0.0024
683 BLISTER 135 0.0024
684 PULMONARY HYPERTENSION 50 0.0024
685 FEELING HOT 147 0.0024
686 ACUTE RESPIRATORY FAILURE 46 0.0024
687 NOCTURIA 29 0.0024
688 RASH MACULO-PAPULAR 53 0.0024
689 SWELLING FACE 155 0.0024
690 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
691 SCAB 27 0.0024
692 HYPERSENSITIVITY 439 0.0024
693 RESPIRATORY FAILURE 172 0.0024
694 MYOCARDITIS 27 0.0024
695 PRESYNCOPE 57 0.0023
696 VIRAL INFECTION 78 0.0023
697 CHOLESTASIS 45 0.0023
698 INSOMNIA 623 0.0023
699 ROTATOR CUFF SYNDROME 30 0.0023
700 RASH MACULAR 81 0.0023
701 FEBRILE NEUTROPENIA 153 0.0023
702 EYE INFLAMMATION 22 0.0023
703 ABDOMINAL PAIN LOWER 58 0.0023
704 THROAT TIGHTNESS 62 0.0023
705 HERPES ZOSTER 131 0.0023
706 HYPOACUSIS 98 0.0023
707 SINUS BRADYCARDIA 22 0.0023
708 ARTHRITIS 179 0.0023
709 HYPOXIA 80 0.0023
710 EMOTIONAL DISORDER 70 0.0023
711 JOINT DISLOCATION 24 0.0023
712 PRODUCT DOSE OMISSION ISSUE 667 0.0023
713 GASTRIC ULCER 43 0.0023
714 GASTROENTERITIS 33 0.0023
715 CYST 28 0.0023
716 SINUS TACHYCARDIA 32 0.0023
717 OBSTRUCTIVE AIRWAYS DISORDER 25 0.0022
718 RENAL TUBULAR NECROSIS 22 0.0022
719 PAIN OF SKIN 60 0.0022
720 RHINORRHOEA 144 0.0022
721 MOBILITY DECREASED 160 0.0022
722 NEUROTOXICITY 39 0.0022
723 COAGULOPATHY 37 0.0022
724 PRODUCT USE ISSUE 417 0.0022
725 ERYTHEMA 455 0.0022
726 MYELODYSPLASTIC SYNDROME 32 0.0022
727 DEVICE RELATED INFECTION 34 0.0022
728 ATRIAL FIBRILLATION 215 0.0022
729 TENDONITIS 34 0.0022
730 HEADACHE 1374 0.0022
731 FLUID RETENTION 110 0.0022
732 RENAL FAILURE 287 0.0022
733 SKIN HAEMORRHAGE 32 0.0022
734 UPPER LIMB FRACTURE 43 0.0022
735 JOINT INJURY 46 0.0022
736 INTESTINAL OBSTRUCTION 81 0.0021
737 CHEST DISCOMFORT 220 0.0021
738 BRONCHITIS 159 0.0021
739 DISEASE RECURRENCE 102 0.0021
740 WEIGHT INCREASED 480 0.0021
741 PANCREATITIS ACUTE 48 0.0021
742 SEPSIS 238 0.0021
743 VERTIGO 130 0.0021
744 HYPONATRAEMIA 120 0.0021
745 ORAL CANDIDIASIS 28 0.0021
746 SINUS DISORDER 42 0.0021
747 DIPLOPIA 55 0.0021
748 EYE DISCHARGE 22 0.0021
749 PNEUMONIA 684 0.0021
750 BODY TEMPERATURE INCREASED 43 0.0021
751 FUNGAL INFECTION 70 0.0021
752 SPEECH DISORDER 110 0.0021
753 ACUTE KIDNEY INJURY 321 0.0021
754 KIDNEY INFECTION 41 0.0021
755 COORDINATION ABNORMAL 29 0.0021
756 ANXIETY 590 0.0021
757 FREQUENT BOWEL MOVEMENTS 56 0.0021
758 ILL-DEFINED DISORDER 125 0.0021
759 NASAL CONGESTION 120 0.0020
760 RESPIRATORY DISORDER 61 0.0020
761 HEPATIC CANCER 49 0.0020
762 COVID-19 PNEUMONIA 24 0.0020
763 SINUSITIS 208 0.0020
764 DEAFNESS 53 0.0020
765 HYPOGLYCAEMIA 98 0.0020
766 INFLUENZA LIKE ILLNESS 166 0.0020
767 GALLBLADDER DISORDER 36 0.0020
768 SOMNOLENCE 404 0.0020
769 DEMENTIA 56 0.0020
770 BALANCE DISORDER 173 0.0020
771 GASTRIC DISORDER 68 0.0020
772 CRYING 72 0.0020
773 RESTLESS LEGS SYNDROME 36 0.0020
774 LOWER LIMB FRACTURE 38 0.0020
775 PRODUCT PRESCRIBING ERROR 47 0.0020
776 GOUT 35 0.0019
777 OBESITY 31 0.0019
778 GASTROINTESTINAL DISORDER 174 0.0019
779 GENERALISED OEDEMA 24 0.0019
780 DEPRESSION 441 0.0019
781 QUALITY OF LIFE DECREASED 26 0.0019
782 HAEMATEMESIS 49 0.0019
783 BACK INJURY 21 0.0019
784 SYNCOPE 193 0.0019
785 TACHYCARDIA 171 0.0019
786 GLAUCOMA 37 0.0019
787 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
788 MUSCLE TIGHTNESS 31 0.0019
789 MOOD ALTERED 52 0.0019
790 BEDRIDDEN 25 0.0019
791 BLOOD PRESSURE DECREASED 126 0.0019
792 ADVERSE REACTION 25 0.0019
793 FALL 623 0.0019
794 HUNGER 26 0.0019
795 INJECTION SITE EXTRAVASATION 23 0.0019
796 ECZEMA 97 0.0019
797 RHABDOMYOLYSIS 77 0.0018
798 FOOT FRACTURE 35 0.0018
799 BACK DISORDER 30 0.0018
800 ACCIDENT 22 0.0018
801 CEREBRAL INFARCTION 45 0.0018
802 BLOOD PRESSURE INCREASED 280 0.0018
803 HEMIPARESIS 31 0.0018
804 CIRCULATORY COLLAPSE 31 0.0018
805 MOOD SWINGS 58 0.0018
806 RESPIRATORY TRACT INFECTION 47 0.0018
807 LIP SWELLING 60 0.0018
808 ANOSMIA 26 0.0018
809 RECTAL HAEMORRHAGE 76 0.0018
810 PALLOR 48 0.0018
811 CONFUSIONAL STATE 285 0.0018
812 VISION BLURRED 241 0.0018
813 POISONING 22 0.0017
814 SARS-COV-2 TEST POSITIVE 23 0.0017
815 THERAPY NON-RESPONDER 78 0.0017
816 DELIRIUM 60 0.0017
817 MENTAL STATUS CHANGES 48 0.0017
818 TYPE 2 DIABETES MELLITUS 58 0.0017
819 LOCAL SWELLING 30 0.0017
820 FAECES DISCOLOURED 37 0.0017
821 LACTIC ACIDOSIS 55 0.0017
822 ADVERSE DRUG REACTION 152 0.0017
823 INJURY 118 0.0017
824 COLON CANCER 25 0.0017
825 HYPERHIDROSIS 216 0.0017
826 LUNG INFECTION 26 0.0017
827 LETHARGY 96 0.0017
828 AGRANULOCYTOSIS 31 0.0017
829 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 87 0.0017
830 FACE OEDEMA 28 0.0017
831 INTENTIONAL DOSE OMISSION 47 0.0016
832 HEART RATE INCREASED 162 0.0016
833 SEPTIC SHOCK 71 0.0016
834 HYPERKALAEMIA 57 0.0016
835 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 78 0.0016
836 INJECTION SITE PAIN 497 0.0016
837 OXYGEN SATURATION DECREASED 91 0.0016
838 HAEMORRHAGE 169 0.0016
839 EYE DISORDER 53 0.0016
840 RASH ERYTHEMATOUS 77 0.0016
841 OFF LABEL USE 1409 0.0016
842 PRODUCT DISPENSING ERROR 35 0.0016
843 ACUTE MYELOID LEUKAEMIA 25 0.0016
844 ARTHROPATHY 89 0.0016
845 PHOTOPHOBIA 30 0.0016
846 MENTAL DISORDER 69 0.0016
847 BLOOD URINE PRESENT 30 0.0016
848 EYE PRURITUS 53 0.0016
849 FEAR 42 0.0016
850 SNEEZING 35 0.0016
851 AMNESIA 101 0.0016
852 MIGRAINE 147 0.0015
853 BASAL CELL CARCINOMA 24 0.0015
854 LUNG NEOPLASM MALIGNANT 63 0.0015
855 STEVENS-JOHNSON SYNDROME 34 0.0015
856 HYPERTHYROIDISM 22 0.0015
857 RASH PAPULAR 34 0.0015
858 INJECTION SITE HAEMATOMA 22 0.0015
859 EYE SWELLING 56 0.0015
860 ANGINA PECTORIS 43 0.0015
861 MUSCULOSKELETAL STIFFNESS 131 0.0015
862 TOXICITY TO VARIOUS AGENTS 249 0.0015
863 SLEEP APNOEA SYNDROME 28 0.0015
864 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
865 ROAD TRAFFIC ACCIDENT 61 0.0015
866 PRODUCT DOSE OMISSION 95 0.0015
867 RESPIRATORY TRACT CONGESTION 23 0.0014
868 ANHEDONIA 38 0.0014
869 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
870 APATHY 21 0.0014
871 URTICARIA 241 0.0014
872 ANAPHYLACTIC REACTION 79 0.0014
873 NEPHROLITHIASIS 65 0.0014
874 PALPITATIONS 163 0.0014
875 DISORIENTATION 55 0.0014
876 JOINT SWELLING 166 0.0014
877 SYRINGE ISSUE 24 0.0014
878 THERAPEUTIC RESPONSE UNEXPECTED 61 0.0014
879 CONDITION AGGRAVATED 411 0.0014
880 COGNITIVE DISORDER 63 0.0013
881 LOWER RESPIRATORY TRACT INFECTION 61 0.0013
882 RESPIRATORY DISTRESS 37 0.0013
883 HEART RATE IRREGULAR 30 0.0013
884 LEUKOCYTOSIS 24 0.0013
885 APHASIA 40 0.0013
886 PROTEINURIA 25 0.0013
887 VAGINAL HAEMORRHAGE 57 0.0013
888 DRUG INEFFECTIVE 1727 0.0013
889 COLD SWEAT 23 0.0013
890 HAEMATOCHEZIA 72 0.0013
891 STAPHYLOCOCCAL INFECTION 43 0.0013
892 ACUTE RESPIRATORY DISTRESS SYNDROME 23 0.0013
893 SKIN CANCER 28 0.0013
894 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 234 0.0013
895 HAEMOPTYSIS 36 0.0013
896 HEART RATE DECREASED 45 0.0013
897 HYPOTENSION 257 0.0013
898 SWOLLEN TONGUE 40 0.0013
899 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
900 WHEEZING 74 0.0012
901 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
902 TINNITUS 57 0.0012
903 COMA 59 0.0012
904 DRUG INTERACTION 195 0.0012
905 TREMOR 204 0.0012
906 DISABILITY 24 0.0012
907 BLOOD PRESSURE FLUCTUATION 29 0.0012
908 CARDIAC DISORDER 113 0.0012
909 POST PROCEDURAL COMPLICATION 23 0.0012
910 CEREBROVASCULAR ACCIDENT 202 0.0012
911 THINKING ABNORMAL 22 0.0012
912 EPILEPSY 36 0.0012
913 DYSARTHRIA 44 0.0012
914 ANAPHYLACTIC SHOCK 30 0.0012
915 MUSCULOSKELETAL DISORDER 22 0.0012
916 PROCEDURAL PAIN 32 0.0012
917 LOSS OF CONSCIOUSNESS 146 0.0011
918 SKIN IRRITATION 52 0.0011
919 MUSCLE TWITCHING 26 0.0011
920 PANIC ATTACK 41 0.0011
921 RASH GENERALISED 29 0.0011
922 INTENTIONAL PRODUCT MISUSE 98 0.0011
923 MENTAL IMPAIRMENT 27 0.0011
924 PRODUCT USE IN UNAPPROVED INDICATION 273 0.0011
925 CARDIAC FAILURE CONGESTIVE 88 0.0011
926 METABOLIC ACIDOSIS 35 0.0011
927 MELAENA 24 0.0011
928 CORONARY ARTERY DISEASE 33 0.0011
929 PRODUCT ADMINISTRATION ERROR 22 0.0011
930 INJECTION SITE SWELLING 83 0.0011
931 SEIZURE 125 0.0011
932 FLUSHING 110 0.0011
933 PERITONITIS 22 0.0011
934 UNDERDOSE 77 0.0011
935 SHOCK 24 0.0010
936 BLOOD GLUCOSE DECREASED 50 0.0010
937 DISTURBANCE IN ATTENTION 56 0.0010
938 VISUAL ACUITY REDUCED 34 0.0010
939 HOSPITALISATION 157 0.0010
940 ENCEPHALOPATHY 25 0.0010
941 ACUTE MYOCARDIAL INFARCTION 30 0.0010
942 OCULAR HYPERAEMIA 48 0.0010
943 THERAPY INTERRUPTED 72 0.0010
944 ACNE 75 0.0010
945 BLINDNESS 40 0.0010
946 INJECTION SITE BRUISING 77 0.0010
947 PNEUMONIA ASPIRATION 24 0.0010
948 IRRITABILITY 57 0.0009
949 HAEMATURIA 32 0.0009
950 ADVERSE EVENT 84 0.0009
951 INJECTION SITE PRURITUS 61 0.0009
952 CARDIAC ARREST 75 0.0009
953 EYE PAIN 51 0.0009
954 EAR INFECTION 24 0.0009
955 CEREBRAL HAEMORRHAGE 32 0.0009
956 NEEDLE ISSUE 26 0.0009
957 THERAPEUTIC RESPONSE DECREASED 54 0.0009
958 AGITATION 63 0.0009
959 INJECTION SITE REACTION 58 0.0008
960 GASTROINTESTINAL HAEMORRHAGE 68 0.0008
961 SKIN BURNING SENSATION 58 0.0008
962 UNEVALUABLE EVENT 61 0.0008
963 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 57 0.0008
964 EYE IRRITATION 45 0.0008
965 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
966 HALLUCINATION 56 0.0007
967 MYOCARDIAL INFARCTION 127 0.0007
968 ANGER 24 0.0007
969 ASTHMA 80 0.0007
970 INTENTIONAL PRODUCT USE ISSUE 62 0.0007
971 ACCIDENTAL OVERDOSE 25 0.0007
972 DRUG DOSE OMISSION 111 0.0007
973 MEDICATION ERROR 36 0.0006
974 CHRONIC KIDNEY DISEASE 49 0.0006
975 INJECTION SITE ERYTHEMA 77 0.0006
976 RENAL FAILURE ACUTE 26 0.0006
977 BRADYCARDIA 32 0.0006
978 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 121 0.0006
980 ANGIOEDEMA 26 0.0006
981 COLITIS ULCERATIVE 26 0.0006
982 SURGERY 34 0.0006
983 EMOTIONAL DISTRESS 68 0.0006
984 PANCREATITIS 26 0.0005
985 INCORRECT DOSE ADMINISTERED 110 0.0005
986 NO ADVERSE EVENT 87 0.0005
987 INJECTION SITE HAEMORRHAGE 36 0.0005
988 TREATMENT NONCOMPLIANCE 22 0.0004
989 BLADDER CANCER 22 0.0004
990 PRODUCT STORAGE ERROR 28 0.0003
991 RHEUMATOID ARTHRITIS 36 0.0003
992 SUICIDAL IDEATION 29 0.0003
993 PSORIASIS 29 0.0002
994 OVERDOSE 44 0.0002
995 PRODUCT QUALITY ISSUE 27 0.0002